Affidea Group’s Fortius Clinic says it completed the acquisition of Schoen Clinic – a dedicated orthopaedic hospital in central London – to bring together ‘a super-specialist group of clinical teams which can provide world-class orthopaedic care and elite sports medicine across the whole patient pathway – from consultation and imaging through to complex surgery and recovery’.
Jim McAvoy, CEO of Fortius Clinic, said: “Fortius has shown the value of super-specialism, with a strong clinical leadership underpinned by a focused governance framework guiding the highest quality care and a culture of learning and innovation. This acquisition enables us to build on our vision to deliver outstanding patient care, and improve outcomes through the latest techniques and research in orthopaedic medicine.”
Guy Blomfield, CEO and Chairman of Affidea Group, said: “The acquisition of Schoen Clinic London is an important milestone for the Affidea Group and for the UK market, which will now create a unique Centre of Excellence in Orthopaedics and Sports Medicine in the heart of London. This strategic move positions us as a front-runner in providing top-tier healthcare solutions in a specialised field, and signals our intent to selectively add more Centres of Excellence to our already extensive offer across the continent.”
In addition to ‘being recognised as the leading expert in elite sport’, Fortius Clinic says it offers a range of surgical treatments – including advanced joint replacements ‘using the very latest in robotic technology’. The clinic ‘has a collaborative approach through sub-specialty teams, sharing knowledge, and combining experience – governed by the same exceptional standards of clinical care and deep expertise that comes from working in a single specialty setting’.
Affidea Group is reportedly the largest European provider of advanced diagnostics, out-of-hospital, and cancer care services, operating over 330 clinics, as well as Centres of Excellence in a variety of specialties, where over 12,000 professionals are seeing more than 12 million patients every year across 15 countries.